Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

In our study, there were no differences in cognitive performance between the groups given donepezil or placebo, irrespective of stimulation therapy or standard care. Chapman et al [12] and Matsuda ...

[20] Another trial comparing donepezil and rivastigmine for up to ... Department of Medicine, UBC Clinic for Alzheimer Disease & Related Dementias, University of British Columbia, Vancouver ...

Data from a large multicenter study demonstrate that donepezil can delay the rate of progression from mild cognitive impairment to Alzheimer disease in patients with depressive symptoms ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

The doctor said his pulse rate is low, and the medications have a tendency to lower the pulse even more, which can be dangerous. His Alzheimer's stage is 4-5, and his MMSE score was 5 out of 30. Is ...

He said: “In donepezil – this is a drug that’s been around for a very long time – it was first developed in mild to moderate Alzheimer’s disease and succeeded, and then it was tested in ...

With these key hires, Alpha Cognition is poised to advance its mission of improving the lives of patients and families ...

Alzheimer's disease (AD ... galantamine in 2008, donepezil and memantine in 2010) and the likely entry of generics, the total value of the AD market might decline around 2010–2011.

Donepezil is under clinical development by Inventage Lab and currently in Phase II for Alzheimer’s Disease. According to GlobalData, Phase II drugs for Alzheimer’s Disease have a 36% phase transition ...

Aricept is approved for all stages of AD, while Razadyne and Exelon are approved for the treatment of mild-to-moderate AD. Alzheimer’s damages cells that produce acetylcholine, which reduces the ...